1.1Vibrating mesh liquid aerosol
A piezoelectric actuator vibrates a perforated membrane in contact with liquid from a reservoir. Liquid passes through the perforations as droplets, and incoming air carries them through the mouthpiece.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A piezoelectric actuator vibrates a perforated membrane in contact with liquid from a reservoir. Liquid passes through the perforations as droplets, and incoming air carries them through the mouthpiece.
A spring drives a piston that presses a metered volume of liquid through two nozzle passages. The two liquid jets meet and break into droplets that the user draws through the mouthpiece.
A pressure regulator feeds a gas mixture from a cylinder to a metering valve. An inspiratory flow sensor triggers the valve to release a measured pulse into the air flowing toward the mouthpiece.
A perforated inlet plate distributes incoming air across the underside of the powder bed. Air passes through the bed toward an aligned outlet and carries particles through a straight duct to the mouthpiece.
A piezoelectric actuator vibrates an inclined tray and moves a premeasured dose to a discharge slot. Powder falls through the slot into the duct, where inhaled air carries it to the mouthpiece.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A cylindrical reservoir holds coarse dry marking powder below a tangential air passage. An axial pickup tube connects the reservoir to a nozzle aimed at a workpiece inside a closed inspection cabinet. A compressed-air ejector at the nozzle draws air through the reservoir, where the rotating flow lifts powder and carries it to the nozzle. A filtered cabinet exhaust collects airborne powder after each marking pulse.
A fixed ring of angled guide vanes replaces the tangential feed passage of a cylindrical powder reservoir. The vane ring sits around the central outlet at the top of the reservoir and directs incoming air downward along the wall. During inhalation, the rotating flow sweeps across the powder bed and returns through the central outlet to the mouthpiece.
A soft silicone nasal olive replaces the oral mouthpiece and fits over a rigid tube connected to the chamber's axial outlet. The chamber holds a dry powder formulated for nasal delivery and has two tangential air passages above the powder bed. With the opposite nostril closed, nasal inhalation draws air through the tangential passages, and the resulting cyclone carries powder through the axial tube into the fitted nostril.
A straight cylindrical cartridge has a 16 mm internal diameter, a 24 mm internal height, and a 5 mm axial outlet connected to the mouthpiece. Two tangential slots, each 2 mm by 4 mm, sit 180 degrees apart with their centers 6 mm below the lid and direct air in the same rotational direction. At a bench draw of 30 L/min through the mouthpiece, the two jets drive rotating flow above a shallow powder bed on the cartridge floor. The axial outlet carries entrained powder out of the cartridge.
A dry powder cyclone cartridge sits in series between an upstream differential-pressure flow sensor and a spirometry mouthpiece. A two-position rotary valve directs inhaled air through either the cartridge or a parallel measurement passage. In the delivery position, inhalation draws air through the cartridge and carries entrained powder to the mouthpiece while the spirometer records inspiratory flow and volume.
A dry powder pocket in the base of a cylindrical cyclone chamber sits beneath a motor-driven sliding shutter. A differential-pressure sensor spans a calibrated restriction upstream of the chamber, and a microcontroller converts the pressure signal to inhalation flow. When the flow exceeds a programmed threshold for 100 ms, the controller retracts the shutter and exposes the powder to the rotating airflow. The controller closes the shutter when flow falls below a lower threshold.
A molded polypropylene mouthpiece has an oval lip opening and a smooth bore that widens toward the exit. The user draws powder carried by air through the bore.
A silicone flap lifts from its seat when the user inhales, allowing powder laden air to pass through the mouthpiece. Exhalation pressure presses the flap against its seat.
A cylindrical chamber holds a premeasured dose of dry powder near its base. Inhalation draws air through a tangential inlet, forming a rotating flow around the chamber axis that carries powder to a central outlet.
An annular ring of angled vanes directs incoming air around the axis of a cylindrical chamber containing dry powder. The rotating airflow lifts powder from the chamber floor and carries it through an axial outlet.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
As the airflow passes by way of channel 138 into and then through the chamber 134, the drug/carrier particles deagglomerate, leaving the carrier particles in chamber 134, while the drug particles travel along the main airflow path MP through the interior 158A of channel member 158 to port 126 of mouthpiece 128, and into the user's mouth.A · US 2008/0314384 A1 · ¶ 95
The inhaler 110 is adapted to dispense dry powder drug/medicament along a main airflow path (MP) extending from ports 118A, through a first piercing tube 124 (not visible in FIG. 1), a foil-faced dose container blister pack 122 (not visible in FIG. 1), a second piercing tube 120 (not visible in FIG. 1), and a drug port 126 in a mouthpiece 128 (not visible in FIG. 1) positioned beneath the mouthpiece protector 114.B · US 2009/0320837 A1 · ¶ 68
The outlet chamber 134 serves as a deagglomerating airflow guide, adapted to effect a separation of relatively small medicament drug particles from relatively large carrier particles entrained in air flow along path MP in use. Preferably, but not necessarily, the chamber 134 is shaped to establish “cyclone” airflow and drug/carrier separation, as described above in conjunction with FIGS. 4-7.A · US 2008/0314384 A1 · ¶ 90
The inlet chamber 132 serves as a reservoir for dry powder medicament-to-be-dispensed. The cyclone chamber 134 serves as a de-agglomerating airflow guide, adapted to effect a separation of relatively small medicament drug particles from relatively large carrier particles entrained in air flow along path MP in use.B · US 2009/0320837 A1 · ¶ 69
An empty cell means only that no passage was reproduced there.
This invention relates to inhalers for delivering substances in powder form to the respiratory system of a user by inhalation.A · US 2008/0314384 A1 · ¶ 1
Moreover, in many devices the FPF is dependent upon the inhalation flow rate of the user so that performance is inconsistent both between users and from one use to the next.A · US 2008/0314384 A1 · ¶ 4
Whilst deposition on the apparatus is preferable to deposition on the back of the throat, it can give rise to a further problem when the deposited powder is dislodged in a subsequent use since this will adversely affect the uniformity of dose received by a user.B · US 2009/0320837 A1 · ¶ 6
It is an object of the invention to provide a dry powder inhaler which alleviates at least some of the problems set out above.B · US 2009/0320837 A1 · ¶ 7
patent.fyi, US 2026/0355438 A1, claim 1, first published 2026-11-19T11:28:41-05:00, https://patent.fyi/US20260355438/, SHA-256 3e3c598c018ad30e7fe7badc813937d6cc81e720b30bd39ccfe4a68211bfd92d